Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| ICU | PRESS-RELEASE | neutral | 1/10 | SeaStar Medical announced it will report its Q1 results on May 13, 2026. | May 6, 2026 |
| STEP | PRESS-RELEASE | neutral | 4/10 | StepStone Group announced a partnership with PitchBook to integrate its proprietary deal-level benchmarks into the Pitch | May 6, 2026 |
| TWIN | PRESS-RELEASE | bullish | 7/10 | Twin Disc reported a strong fiscal Q3 2026 beat, with EPS of $0.23 vs a loss of ($0.11) a year ago and revenue up 19% Yo | May 6, 2026 |
| URGN | PRESS-RELEASE | bullish | 7/10 | UroGen reported Q1 2026 total revenue of $51.0M (+152% YoY), driven by ZUSDURI's launch ($29.2M, +109% QoQ) and JELMYTO | May 6, 2026 |
| TSHA | PRESS-RELEASE | mixed | 7/10 | Taysha reported Q1 2026 EPS of -$0.12 (GAAP), wider than the -$0.08 consensus, with zero revenue vs $2.3M a year ago. Th | May 6, 2026 |
| NVGS | PRESS-RELEASE | mixed | 6/10 | The company announced a revised capital return policy increasing the payout ratio from 30% to 35% of net income, and sig | May 6, 2026 |
| HLLY | PRESS-RELEASE | bearish | 7/10 | Holley reported Q1 2026 EPS of $0.04, a 27.3% miss vs $0.06 consensus, on revenue of $147.3M (-3.7% YoY) that missed the | May 6, 2026 |
| STEP | PRESS-RELEASE | neutral | 1/10 | StepStone Group Inc announced it will report its fiscal Q4 2026 results on May 20, 2026. | May 6, 2026 |
| BCTXL | PRESS-RELEASE | neutral | 5/10 | BriaCell received FDA clearance to begin a Phase 1/2a clinical trial for Bria-BRES+, its next-generation personalized im | May 6, 2026 |
| ALT | PRESS-RELEASE | neutral | 1/10 | Altimmune, Inc announced it will report its Q1 2026 results on May 13, 2026. | May 6, 2026 |
| MDLN | PRESS-RELEASE | bearish | 8/10 | Medline reported Q1 2026 GAAP EPS of $0.01, a 96.6% miss vs consensus of $0.29, and net income fell 25.8% YoY to $239M. | May 6, 2026 |
| MDCX | PRESS-RELEASE | bullish | 7/10 | Medicus Pharma announced positive dose-response results from an expanded analysis of its Phase 2 SKNJCT-003 study for Do | May 6, 2026 |
| BBIO | PRESS-RELEASE | bullish | 7/10 | BridgeBio Pharma announced that Brazilian health regulator ANVISA approved acoramidis (BEYONTTRA) for ATTR-CM, adding a | May 6, 2026 |
| BVS | PRESS-RELEASE | bullish | 8/10 | Bioventus reported Q1 2026 revenue of $132.1M (+7% YoY) and GAAP EPS of $0.04, swinging from a -$0.04 loss in the prior | May 6, 2026 |
| XFOR | PRESS-RELEASE | mixed | 6/10 | X4 Pharmaceuticals reported Q1 2026 revenue of $2.7M (vs $3.2M consensus) and GAAP EPS of -$0.16 (vs consensus -$0.20, a | May 6, 2026 |
| GRO | PRESS-RELEASE | neutral | 4/10 | Brazil Potash awarded a FEED contract to a Wood-Promon consortium for the Autazes project's surface infrastructure, a ke | May 6, 2026 |
| RXRX | PRESS-RELEASE | mixed | 6/10 | Recursion Pharmaceuticals reported Q1 2026 EPS of -$0.21, beating consensus of -$0.26 by 18.3%, while revenue of $6.5M m | May 6, 2026 |
| BESS | PRESS-RELEASE | neutral | 4/10 | Bimergen Energy announced SMA as the inverter supplier for an 80 MW BESS portfolio in ERCOT, funded via non-dilutive pro | May 6, 2026 |
| EGAN | PRESS-RELEASE | neutral | 1/10 | eGain Corporation announced it will report its fiscal Q3 2026 results on May 14, 2026. | May 6, 2026 |
| APO | PRESS-RELEASE | bullish | 8/10 | Apollo reported Q1 2026 EPS of $2.47, a 31.0% beat vs. consensus of $1.88, and AUM surpassed $1 trillion for the first t | May 6, 2026 |
| TBLA | PRESS-RELEASE | bullish | 7/10 | Taboola reported Q1 2026 revenue of $466.4M (+9.1% YoY) and GAAP net income of $59.1M (vs -$8.8M loss a year ago), drive | May 6, 2026 |
| UCL | PRESS-RELEASE | neutral | 1/10 | uCloudlink Group Inc. announced it will report its Q1 2026 results on May 13, 2026. | May 6, 2026 |
| FTS | PRESS-RELEASE | neutral | 3/10 | Fortis reported Q1 2026 net earnings of $501M (EPS $0.99), slightly below prior year's $1.00, reflecting regulatory timi | May 6, 2026 |
| CVE | PRESS-RELEASE | mixed | 6/10 | Cenovus Energy reported Q1 2026 EPS of $0.50, a 9.3% miss vs consensus of $0.55, and revenue of $12.4B (below $13.73B co | May 6, 2026 |
| PRM | PRESS-RELEASE | bullish | 7/10 | Perimeter Solutions reported Q1 2026 net sales of $125.1M (+74% YoY) and GAAP diluted EPS of $0.44, far exceeding the $0 | May 6, 2026 |
| PONY | PRESS-RELEASE | neutral | 1/10 | Pony AI Inc. announced it will report its Q1 2026 results on May 26, 2026. | May 6, 2026 |
| SFL | PRESS-RELEASE | neutral | 1/10 | SFL Corporation announced it will report its Q1 2026 results on May 12, 2026. | May 6, 2026 |
| PHG | PRESS-RELEASE | neutral | 4/10 | Royal Philips reported Q1 2026 comparable sales growth of 4% to EUR 3.9 billion and adjusted EBITA margin expansion of 4 | May 6, 2026 |
| AVTX | PRESS-RELEASE | bearish | 7/10 | Avalo Therapeutics priced a $375M underwritten public offering of 19.73M shares at $17.75/share plus pre-funded warrants | May 5, 2026 |
| RSI | PRESS-RELEASE | neutral | 5/10 | Rush Street Interactive announced a secondary offering of 10 million shares by its Executive Chairman, CEO, and COO at $ | May 5, 2026 |